The importance of stewardship in agricultural biotechnology by Phillips, Michael J.
35
An important issue that concerns us at BIO is that the biotechnology industry be good 
stewards. We expect that this will be important for a long time to come. Good stewardship 
relates to regulatory policy and—contrary to the philosophy that we need less regula-
tion—at BIO we understand the role that regulatory policy plays and we embrace it. It 
is the backbone for all that we do to ensure biotechnology’s success.
The Importance of Stewardship in Agricultural 
Biotechnology
Michael J. Phillips
Biotechnology	Industry	Organization
Washington,	DC
BIO is a trade association representing all facets of biotechnology. We have over ,00 
member companies—90% of which are small entrepreneurial entities—academic institu-
tions and state centers here in the United States. We have members in all fifty states and 
in thirty-four nations, and we are involved in r&D across all of the sectors, including 
food and agriculture, healthcare and industrial manufacturing. Our 005 annual meet-
ing in Philadelphia had close to 9,000 attendees, a record number indicating how this 
technology is growing in importance.
It can be hard to tell where food and agriculture ends and healthcare and industrial 
aspects begin, particularly in terms of plant-made pharmaceuticals (PMPs) and industrial 
products (PMIPs). It is appropriate, therefore, for BIO to examine all facets of biotech-
nology, particularly in terms of synergisms across these sectors.
005 marked the tenth anniversary of commercial planting of biotech crops. This, the 
most rapidly adopted technology in the history of agriculture, now plays an extremely 
important role for soybean, cotton, corn and canola, representing well over two thirds of 
all of the varieties that are being planted. 005 also marked the cumulative planting of 
one billion acres of biotech crops around the world, the achievement of which all of us 
who are part of this industry may be proud.
At	BIO	we	understand	the	role	that	regulatory	policy	plays	and	
we	embrace	it.
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ten years ago, we focused on agronomic traits. We have begun to move into quality 
traits and are now developing plants as factories for synthesis of pharmaceuticals and 
industrial products and materials—the third wave.
The United States has evolved an elaborate regulatory system that we refer to as the 
Coordinated regulatory Framework. There is a lot of history here, going back to the late 
980s. It is a science- and risk-based regulatory system and is transparent, and we are 
working with the regulatory agencies—USDA, EPA and FDA—to ensure that it will 
become more transparent in the future. The biotech industry has always embraced strong 
regulatory policy and oversight; we cannot overstate how important this is to us in terms 
of promoting consumer confidence.
Stewardship Areas
Within BIO, we have a robust training program and an active group is laying out prin-
ciples for development and confinement of PMPs and PMIPs. And late in 00, BIO 
released a containment analysis and critical control point (CACCP) plan for PMP and 
PMIP production. These areas constitute a strong stewardship program to help ensure 
that we are meeting all federal requirements.
Compliance training
A couple of years ago, the author met with the NABC board to discuss aspects of train-
ing deemed mutually important. We have now developed educational workshops dealing 
with compliance aspects affecting genetically engineered (GE) corn, cotton and soybeans. 
These workshops will be offered in conjunction with professional society meetings and 
conferences such as those organized by NABC. Not only do we want those in our industry 
to participate in these training courses, they will be offered also to universities and federal 
research agencies to help ensure that all abide by the federal requirements and understand 
the legal implications involved in conducting field trials with GE crops.
In	2004,	BIO	released	a	containment	analysis	and	critical	
control	point	(CACCP)	plan	for	PMP	and	PMIP	production.
Furthermore, we are planning to provide accreditation as part of the incentive to 
participate in these training programs. We are optimistic that we will be able to offer 
continuing education credits (CECs). We hope to begin offering classes and workshops 
in the fall of 005 in conjunction with professional society meetings and be fully opera-
tion throughout 00 and beyond. 
We	are	planning	to	provide	accreditation	as	part	of	the	incentive	
to	participate	in	these	training	programs.
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What will be involved? The courses will cover notification and permitting procedures, 
compliance and enforcement, transport and storage, trial-site management, harvest dis-
position and post-harvest management. An important aspect is auditing and verification, 
particularly by third parties, also requirements to be met with pesticidal products with 
regards to Environmental Use Permits. One-day workshops are envisioned; in some cases 
a half-day or two-thirds of a day may suffice.
CACCP
Within the PMP/PMIP arena, we have been working on drawing up principles for de-
velopment and confinement. A reference document that we published looks at two areas. 
One is the principle for controlled exposures to PMPs and PMIPs, and the other describes 
development practices for PMPs and PMIPs, which examines confinement systems that 
control exposure and cross-pollination, confirmation of confinement and the use of 
identity preservation systems. In 00, we finished the second phase of this project; the 
principles document was reduced down to a confinement analysis and critical control 
points (CACCP) approach to PMP and PMIP production. This terminology resonates 
with people in the food industry who understand the hazard analysis and critical control 
point (HACCP) system (which relates to risk analysis and food safety) which has many 
elements in common with risk assessment and management of PMPs and PMIPs.
The CACCP system entails seven principles: how the critical control points are deter-
mined, how limits are established, how the process is monitored (a very important aspect), 
how corrective actions are to be initiated, how verification procedures are establish, and 
record keeping and documentation. Whether in industry, at a university or within a 
federal research agency, all of these principles apply. 
Commitment of top management is essential. Prerequisites include GMPs and other 
good Q&A protocols, facility standards, supplier control, cleaning and sanitation, etc. Of 
primary importance are education and training, and as our compliance training programs 
evolve, we will include modules covering the CACCP system, for example. Participants in 
the training courses will return to their universities, companies or research agencies and 
develop institutional standard operating procedures to fit specific home-base needs.
For	biotechnology	to	continue	to	evolve,	commitment	to	good	
stewardship	on	the	part	of	the	industrial	sector	will	be	essential,	
together	with	embracement	of	federal	regulatory	policies.
Summary
Stewardship is an extremely important aspect of the development of biotechnology, one 
that BIO’s membership takes very seriously. Our goals include the highest standards of 
performance, to demonstrate transparency, openness and commitment to regulatory 
compliance. For biotechnology to continue to evolve, commitment to good stewardship 
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on the part of the industrial sector will be essential, together with embracement of federal 
regulatory policies.
More information is available at http://www.bio.org or from the author at mphillips@
bio.org.
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